The beginning of a new era in medicine: The U.S. FDA has today approved cell-based gene therapy Casgevy, marking the first FDA-approved therapy utilising the genome editing technology CRISPR (NASDAQ:CRSP) | https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease
#FDA #CRISPR #shorts
ODA
0.115
167.4%
JDO
0.915
-40.4%
AOK
0.003
50%
FBR
0.002
-33.3%
NX1
0.018
38.5%
MFD
0.16
-33.3%
T3D
0.046
31.4%
UM1
0.1
-31%
EIQ
1.615
30.2%
M2M
0.007
-30%
DXN
0.23
27.8%
CLU
0.005
-28.6%
BSR
0.465
27.4%
ALY
0.006
-25%
DME
0.04
25%
BLU
0.003
-25%
FCT
0.01
25%
CAN
0.003
-25%
NPM
0.016
23.1%
CCR
0.15
-25%
CLA
0.006
20%
NMT
0.021
-25%
OEL
0.006
20%
TON
0.003
-25%
OSM
0.62
17%
TSK
0.065
-23.5%
MEM
0.007
16.7%
AM3
0.004
-20%
PET
0.007
16.7%
IBX
0.012
-20%
SKM
0.25
16.3%
T88
0.04
-20%
SFX
0.041
13.9%
DTM
0.013
-18.8%
PTX
0.066
13.8%
AUV
0.009
-18.2%
3PL
0.335
13.6%
INF
0.009
-18.2%
CXL
0.475
13.1%
KNG
0.045
-18.2%
